Human medicines European public assessment report (EPAR): Icotyde, icotrokinra hydrochloride, Status: Opinion
Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion
Human medicines European public assessment report (EPAR): Lynavoy, Linerixibat, Status: Opinion
Human medicines European public assessment report (EPAR): Lyrokaul, lerodalcibep, Status: Opinion
Human medicines European public assessment report (EPAR): Meplyffa, arimoclomol, Status: Opinion
Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Ubeslo, obicetrapib, Status: Opinion
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Status: Opinion
Summary of opinion: Rinvoq, 23/07/2026 Positive